» Articles » PMID: 22246185

Rsk-mediated Phosphorylation and 14-3-3ɛ Binding of Apaf-1 Suppresses Cytochrome C-induced Apoptosis

Overview
Journal EMBO J
Date 2012 Jan 17
PMID 22246185
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Many pro-apoptotic signals trigger mitochondrial cytochrome c release, leading to caspase activation and ultimate cellular breakdown. Cell survival pathways, including the mitogen-activated protein kinase (MAPK) cascade, promote cell viability by impeding mitochondrial cytochrome c release and by inhibiting subsequent caspase activation. Here, we describe a mechanism for the inhibition of cytochrome c-induced caspase activation by MAPK signalling, identifying a novel mode of apoptotic regulation exerted through Apaf-1 phosphorylation by the 90-kDa ribosomal S6 kinase (Rsk). Recruitment of 14-3-3ɛ to phosphorylated Ser268 impedes the ability of cytochrome c to nucleate apoptosome formation and activate downstream caspases. High endogenous levels of Rsk in PC3 prostate cancer cells or Rsk activation in other cell types promoted 14-3-3ɛ binding to Apaf-1 and rendered the cells insensitive to cytochrome c, suggesting a potential role for Rsk signalling in apoptotic resistance of prostate cancers and other cancers with elevated Rsk activity. Collectively, these results identify a novel locus of apoptosomal regulation wherein MAPK signalling promotes Rsk-catalysed Apaf-1 phosphorylation and consequent binding of 14-3-3ɛ, resulting in decreased cellular responsiveness to cytochrome c.

Citing Articles

circSORBS1 inhibits lung cancer progression by sponging miR-6779-5p and directly binding RUFY3 mRNA.

Xu H, Zheng Y, Wu J, Zhang R, Zhao Q, Chen S J Transl Med. 2024; 22(1):590.

PMID: 38915053 PMC: 11197270. DOI: 10.1186/s12967-024-05423-0.


Caspase 3-specific cleavage of MEK1 suppresses ERK signaling and sensitizes cells to stress-induced apoptosis.

Moriizumi H, Kubota Y, Tsuchiya T, Naka R, Takekawa M FEBS Open Bio. 2023; 13(4):684-700.

PMID: 36776127 PMC: 10068311. DOI: 10.1002/2211-5463.13574.


Fusion genes in gynecologic tumors: the occurrence, molecular mechanism and prospect for therapy.

Lu B, Jiang R, Xie B, Wu W, Zhao Y Cell Death Dis. 2021; 12(8):783.

PMID: 34381020 PMC: 8357806. DOI: 10.1038/s41419-021-04065-0.


Costunolide attenuates oxygen‑glucose deprivation/reperfusion‑induced mitochondrial‑mediated apoptosis in PC12 cells.

Meng L, Ma H, Meng J, Li T, Zhu Y, Zhao Q Mol Med Rep. 2021; 23(6).

PMID: 33786628 PMC: 8025489. DOI: 10.3892/mmr.2021.12050.


Reversal of homocysteine-induced neurotoxicity in rat hippocampal neurons by astaxanthin: evidences for mitochondrial dysfunction and signaling crosstalk.

Wang X, Chen W, Fu X, Ma J, Wang M, Hou Y Cell Death Discov. 2018; 4:50.

PMID: 30374413 PMC: 6197197. DOI: 10.1038/s41420-018-0114-x.


References
1.
Li Z, Zhao J, Du Y, Park H, Sun S, Bernal-Mizrachi L . Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation. Proc Natl Acad Sci U S A. 2007; 105(1):162-7. PMC: 2224179. DOI: 10.1073/pnas.0710905105. View

2.
Liang X, Butterworth M, Peters K, Walker W, Frizzell R . An obligatory heterodimer of 14-3-3beta and 14-3-3epsilon is required for aldosterone regulation of the epithelial sodium channel. J Biol Chem. 2008; 283(41):27418-27425. PMC: 2562081. DOI: 10.1074/jbc.M803687200. View

3.
Nomura M, Shimizu S, Sugiyama T, Narita M, Ito T, Matsuda H . 14-3-3 Interacts directly with and negatively regulates pro-apoptotic Bax. J Biol Chem. 2002; 278(3):2058-65. DOI: 10.1074/jbc.M207880200. View

4.
Hausmann G, OReilly L, VAN Driel R, Beaumont J, Strasser A, Adams J . Pro-apoptotic apoptosis protease-activating factor 1 (Apaf-1) has a cytoplasmic localization distinct from Bcl-2 or Bcl-x(L). J Cell Biol. 2000; 149(3):623-34. PMC: 2174854. DOI: 10.1083/jcb.149.3.623. View

5.
Srinivasula S, Ahmad M, Fernandes-Alnemri T, Alnemri E . Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell. 1998; 1(7):949-57. DOI: 10.1016/s1097-2765(00)80095-7. View